EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Picroside II suppresses chondrocyte pyroptosis through MAPK/NF-κB/NLRP3 signaling pathway alleviates osteoarthritis

Fanchen Wang iD, Jiacong Xiao, Miao Li, Qi He, Xintian Wang, Zhaofeng Pan, Shaocong Li, Haibin Wang, Chi Zhou iD

PLOS ONE · 29.08.2024 · 19 (8) · e0308731

DOI: 10.1371/journal.pone.0308731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 29.08.2024. Verfasst von Fanchen Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: First School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Chondrocytes, Iridoid Glucosides, NLR Family, Pyrin Domain-Containing 3 Protein, Pyroptosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Administration of Traditional Chinese Medicine, Guangzhou Municipal Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Picroside II (P-II) is the main bioactive constituent of Picrorhiza Kurroa, a traditional Chinese herb of interest for its proven anti-inflammatory properties. Its beneficial effects have been noted across several physiological systems, including the nervous, circulatory, and digestive, capable of treating a wide range of diseases. Nevertheless, the potential of Picroside II to treat osteoarthritis (OA) and the mechanisms behind its efficacy remain largely unexplored.

Aim

This study aims to evaluate the efficacy of Picroside II in the treatment of osteoarthritis and its potential molecular mechanisms.

Methods

In vitro, we induced cellular inflammation in chondrocytes with lipopolysaccharide (LPS) and subsequently treated with Picroside II to assess protective effect on chondrocyte. We employed the Cell Counting Kit-8 (CCK-8) assay to assess the impact of Picroside II on cell viability and select the optimal Picroside II concentration for subsequent experiments. We explored the effect of Picroside II on chondrocyte pyroptosis and its underlying molecular mechanisms by qRT-PCR, Western blot (WB) and immunofluorescence. In vivo, we established the destabilization of the medial meniscus surgery to create an OA mouse model. The therapeutic effects of Picroside II were then assessed through Micro-CT scanning, Hematoxylin-eosin (H&E) staining, Safranin O-Fast Green (S&F) staining, immunohistochemistry and immunofluorescence.

Results

In in vitro studies, toluidine blue and CCK-8 results showed that a certain concentration of Picroside II had a restorative effect on the viability of chondrocytes inhibited by LPS. Picroside II notably suppressed the expression levels of caspase-1, IL-18, and IL-1β, which consequently led to the reduction of pyroptosis. Moreover, Picroside II was shown to decrease NLRP3 inflammasome activation, via the MAPK/NF-κB signaling pathway. In vivo studies have shown that Picroside II can effectively reduce subchondral bone destruction and osteophyte formation in the knee joint of mice after DMM surgery.

Conclusions

Our research suggests that Picroside II can inhibit chondrocyte pyroptosis and ameliorate osteoarthritis progression by modulating the MAPK/NF-κB signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrocytesIridoid GlucosidesNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisCinnamatesNF-kappa BOsteoarthritisAnimalsMiceSignal TransductionMaleMAP Kinase Signaling SystemLipopolysaccharidesMice, Inbred C57BL

Substanzen

Iridoid Glucosidespicroside IINLR Family, Pyrin Domain-Containing 3 ProteinCinnamatesNF-kappa BLipopolysaccharidesNlrp3 protein, mouse

Autor:innen und Institutionen

  • First School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • The Laboratory of Orthopedics and Traumatology of Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Department of Orthopedic Surgery, The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Maoming Hospital of Guangzhou University of Chinese Medicine, Maoming, China.

ORCID-Profile: Fanchen Wang, Chi Zhou

Förderung

  • National Natural Science Foundation of China
  • Guangdong Provincial Administration of Traditional Chinese Medicine
  • Guangzhou Municipal Science and Technology Project
  • Maoming Science and Technology Bureau

Zitieren

APA

Wang, F., Xiao, J., Li, M., He, Q., Wang, X., Pan, Z., Li, S., Wang, H., & Zhou, C. (2024). Picroside II suppresses chondrocyte pyroptosis through MAPK/NF-κB/NLRP3 signaling pathway alleviates osteoarthritis. PLOS ONE, 19(8), e0308731. https://doi.org/10.1371/journal.pone.0308731

Vancouver

Wang F, Xiao J, Li M, He Q, Wang X, Pan Z, et al. Picroside II suppresses chondrocyte pyroptosis through MAPK/NF-κB/NLRP3 signaling pathway alleviates osteoarthritis. PLOS ONE. 2024;19(8):e0308731. doi:10.1371/journal.pone.0308731

BibTeX
@article{Wang2024,
  author = {Wang, Fanchen and Xiao, Jiacong and Li, Miao and He, Qi and Wang, Xintian and Pan, Zhaofeng and Li, Shaocong and Wang, Haibin and Zhou, Chi},
  title = {Picroside II suppresses chondrocyte pyroptosis through MAPK/NF-κB/NLRP3 signaling pathway alleviates osteoarthritis},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {8},
  pages = {e0308731},
  doi = {10.1371/journal.pone.0308731}
}
Kostenlos starten →